Evidence map›Paper›PMID 32810960›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Effect of imatinib on the height of children with chronic myeloid leukemia in the chronic phase].

F Y Zheng, Yanli Zhang, L Q Zhang, B C Liu, L Meng, J Jin, H L Liu, Z M Sun, L E Lin, P C Lei and 18 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 18 institutions in 1 country.

F Y ZhengPeking University People's Hospital, Beijing 100044, China.
Yanli ZhangHenan Cancer Hospital, Zhengzhou 450008, China.
L Q ZhangBeijing Children's Hospital Affiliated to Capital Medical University, Beijing 100045, China.
B C LiuInstitute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
L MengTongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan 430030, China.
J JinThe First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou 310003, China.
H L LiuAffiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
Z M SunAffiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
L E LinHainan General Hospital, Haikou 570311, China.
P C LeiHenan Provincial People's Hospital, Zhengzhou 450003, China.
X F ZhuInstitute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
H X MaThe Third Hospital of Zhengzhou, Zhengzhou 450003, China.
Z S LuGuangdong General Hospital, Guangzhou 510080, China.
H JiangGuangzhou Women and Children's Medical Center, Guangzhou 510623, China.
Y H ZhaoThe First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
H LinJilin University First Hospital, Changchun 130021, China.
X ZhangMaoming People's Hospital, Maoming 525000, China.
G P YangThe First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
H L ZhuWest China Hospital of Sichuan University, Chengdu 610041, China.
S N ChenThe First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Y YouUnion Hospital Affiliated to Huazhong University of Science and Technology, Wuhan 430022, China.
W M LiUnion Hospital Affiliated to Huazhong University of Science and Technology, Wuhan 430022, China.
Q X BaiXijing Hospital of Air Force Medical University, Xi'an 710032, China.
X L ZhaoXiangya Hospital of Central South University, Changsha 410008, China.
Z Y LiAffiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
X M ShenThe First People's Hospital of Yunnan Province, Kunming 650034, China.
L P ZhangPeking University People's Hospital, Beijing 100044, China.
Q JiangPeking University People's Hospital, Beijing 100044, China.
Institute of Hematology & Blood Diseases Hospital · CNPeking University · CNBeijing Children’s Hospital · CNFirst Affiliated Hospital of Harbin Medical University · CNFirst Affiliated Hospital of Soochow University · CNFirst Affiliated Hospital Zhejiang University · CNFirst People's Hospital of Yunnan Province · CNGuangdong General Hospital · CNGuangzhou Women and Children Medical Center · CNHainan General Hospital · CNHenan Cancer Hospital · CNHenan Provincial People's Hospital · CNNanchang University · CNPeking University People's Hospital · CNSichuan University · CNTongji Hospital · CNXiangya Hospital Central South University · CNXuzhou Medical College · CN

Funding

National Natural Science Foundation of China 81770161
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveAdolescentAdultAntineoplastic AgentsChildChild, PreschoolChinaFemaleHumansImatinib MesylateInfantMaleTime FactorsTreatment OutcomeYoung AdultAntineoplastic AgentsImatinib MesylateChildrenChronic-phaseHeightImatinibLeukemia, myeloid, chronic

Identifiers

PMID32810960
PMCPMC7449767
OpenAlexW3080224851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.